| Ytd | 61.74% | |
| 1y | 21.50% |
| Open | 132.49 | Prev Close | 132.53 | Low | 129.19 | High | 132.54 | Mkt Cap | 6.10B |
| Vol | 6.57K | Avg Vol | 724.01K | EPS | 0.55 | P/E | 240.96 | Forward P/E | 123.08 |
| Beta | N/A | Short Ratio | 2.90 | Inst. Own | 37.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 105.58 | 200-d Avg | 92.92 | 1yr Est | 119.29 |
BLLN News
Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the natio
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gene
According to a Form 4 filing, a BillionToOne executive sold 801 shares of Class A Common Stock at $1
Tom Gardner makes the case for fifty-stock portfolios and AI-powered research, then names five compa
Here is how BillionToOne (BLLN) and Concentra Group (CON) have performed compared to their sector so
BillionToOne's Northstar Response Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-o
Tissue-free ctDNA monitoring was the dominant independent predictor of survival across 12 tumor type
Guggenheim analyst Subbu Nambi initiates coverage on BillionToOne (NASDAQ:BLLN) with a Buy rating
Here is how BillionToOne (BLLN) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to t
MENLO PARK, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gener
During the quarter, we added 9 new positions and exited 11 positions, bringing the number of positio
The average of price targets set by Wall Street analysts indicates a potential upside of 37% in Bill
Cramer likes Silicon Motion, whose shares fell 2.2% to settle at $263.85 on Thursday. Wynn shares de
The mean of analysts' price targets for BillionToOne (BLLN) points to a 25.6% upside in the stock. W
Although the revenue and EPS for BillionToOne (BLLN) give a sense of how its business performed in t
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gener
A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk scree
Renowned physician executive and clinician-scientist joins BillionToOne to advance oncology medical
Shares of Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) have received a consensus recommendati
BillionToOne, Inc. (BLLN) Q4 2025 Earnings Call Transcript
BillionToOne delivers strong growth in molecular diagnostics, achieving profitability and raising 20
Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) saw unusually-strong trading volume on Thursday
Summary:Top Wall Street analysts changed outlook on top names. Analyst ratings page shows all chang
